XWEL
XWELL Inc.
NASDAQ: XWEL · HEALTHCARE · DIAGNOSTICS & RESEARCH
$1.18
+2.61% today
Updated 2026-04-30
Market cap
$9.43M
P/E ratio
—
P/S ratio
0.32x
EPS (TTM)
$-5.08
Dividend yield
—
52W range
$0 – $2
Volume
10.0M
XWELL Inc. (XWEL) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-7.30M | $-4.85M | $-6.36M | $-5.38M | $-14.47M | $-23.46M | $-28.38M | $-2.57M | $-8.44M | $-12.17M | $-6.57M | $-113000.00 | $-25.01M | $15.64M | $-24.19M | $-16.07M | $-11.01M | $-8.71M |
| Capital expenditures | $101000.00 | $33000.00 | $86000.00 | $27000.00 | $22.76M | $1.44M | $246000.00 | $0.00 | $641000.00 | $4.71M | $3.12M | $2.27M | $4.35M | $8.67M | $6.84M | $2.37M | $1.79M | $2.96M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $48000.00 | $167000.00 | $-15000.00 | $1.77M | $8.09M | $12.09M | $10.97M | $5.06M | $2.57M | $2.18M | $916000.00 | $335000.00 | $1.33M | $2.86M | $3.87M | $2.32M | $893000.00 | $1.08M |
| Free cash flow | $-7.40M | $-4.88M | $-6.45M | $-5.41M | $-37.22M | $-24.91M | $-28.63M | $-2.57M | $-9.08M | $-16.88M | $-9.68M | $-2.39M | $-29.36M | $6.97M | $-31.02M | $-18.45M | $-12.80M | $-11.68M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | $13000.00 | — | — | — | $267000.00 |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |